BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2995691)

  • 41. Antibodies unrelated to Epstein-Barr virus in human sera which precipitate soluble components of cultured lymphoblasts.
    Guerra A; Koldovsky U; Henle W
    J Natl Cancer Inst; 1974 Nov; 53(5):1193-200. PubMed ID: 4372375
    [No Abstract]   [Full Text] [Related]  

  • 42. Circulating epstein-barr virus in children living in malaria-endemic areas.
    Rasti N; Falk KI; Donati D; Gyan BA; Goka BQ; Troye-Blomberg M; Akanmori BD; Kurtzhals JA; Dodoo D; Consolini R; Linde A; Wahlgren M; Bejarano MT
    Scand J Immunol; 2005 May; 61(5):461-5. PubMed ID: 15882438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fluctuation in Epstein-Barr virus-related antibody titers by age: response differences between the IgG antibodies to VCA and anti-EBNA antibodies].
    Kumagai E; Tanaka R; Kumagai T; Katsuki T; Sawada S
    Rinsho Byori; 1984 Jun; 32(6):666-70. PubMed ID: 6092744
    [No Abstract]   [Full Text] [Related]  

  • 44. Observations of the aetiology of primary intestinal lymphoma.
    Bakir F; Al-Bahrani ZR
    J Infect; 1982 May; 4(3):221-3. PubMed ID: 6309979
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunoglobulin response in malaria in Ethiopia: association of splenomegaly with increased concentration of IgM.
    Watkins RP; Butler WT
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):708-11. PubMed ID: 4629090
    [No Abstract]   [Full Text] [Related]  

  • 46. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients.
    Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR
    Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981
    [No Abstract]   [Full Text] [Related]  

  • 47. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
    Henle W; Henle G
    Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
    [No Abstract]   [Full Text] [Related]  

  • 48. Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment.
    Donati D; Espmark E; Kironde F; Mbidde EK; Kamya M; Lundkvist A; Wahlgren M; Bejarano MT; Falk KI
    J Infect Dis; 2006 Apr; 193(7):971-7. PubMed ID: 16518759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sero-epidemiologic studies of Epstein-Barr virus in Israel].
    Oren U; Gotlieb-Stematsky T; Doley E; Modan M
    Harefuah; 1978 Mar; 94(5-6):171-2. PubMed ID: 207624
    [No Abstract]   [Full Text] [Related]  

  • 50. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
    Morrow RH; Sever JL; Henderson BE
    Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
    [No Abstract]   [Full Text] [Related]  

  • 51. Association of Epstein-Barr virus and American Burkitt's lymphoma.
    Easton JM; Ablashi DV; Levine PH; Armstrong GR
    IARC Sci Publ (1971); 1975; (11 Pt 2):37-43. PubMed ID: 191381
    [No Abstract]   [Full Text] [Related]  

  • 52. Epstein-Barr virus specific antibodies in patients with IgA nephropathy.
    Wu AY; Lau YK; Chia KB; Lim CH
    Singapore Med J; 1988 Jun; 29(3):257-60. PubMed ID: 2847323
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
    Magrath I; Henle W; Owor R; Olweny C
    N Engl J Med; 1975 Mar; 292(12):621-3. PubMed ID: 163432
    [No Abstract]   [Full Text] [Related]  

  • 54. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
    Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
    Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus-related serology in Hodgkin's disease.
    Henle W; Henle G
    Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
    [No Abstract]   [Full Text] [Related]  

  • 56. Seroepidemiology of Epstein-Barr virus infections in a developing country.
    Hossain A
    J Trop Pediatr; 1987 Oct; 33(5):257-60. PubMed ID: 2828648
    [No Abstract]   [Full Text] [Related]  

  • 57. Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt's lymphoma.
    Morrow RH
    IARC Sci Publ; 1985; (60):177-86. PubMed ID: 3905588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
    Henle W; Henle G; Ho JH
    IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
    [No Abstract]   [Full Text] [Related]  

  • 59. [Lymphatic diseases specific to the tropics (Burkitt's lymphoma, tropical splenomegaly and Mediterranean lymphoma)].
    Kern P
    Wien Klin Wochenschr; 1984 Jul; 96(14):529-35. PubMed ID: 6089444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody against synthetic peptide derived from Epstein-Barr virus-determined nuclear antigen 1 (EBNA-1) in child non-Hodgkin's lymphoma.
    Sova P; Roubalová K; Weinreb M; Hamsíková E; Kodet R; Krchnák V; Roubal J
    Acta Virol; 1990 Apr; 34(2):132-8. PubMed ID: 1975974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.